FDA gives OK to use rotavirus vaccines, adds contraindication

The Food and Drug Administration (FDA) determined on May 14 that it is appropriate for U.S. clinicians and public health providers to resume the use of Rotarix (GlaxoSmithKline Biologicals) and to continue the use of RotaTeq (Merck & Co. Inc.) rotavirus vaccines. In addition, a contraindication for